It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 | Mumbai, Maharashtra, India | ActiveMediverve Laboratories Private Limited, a active private limited company, was established on 30 December 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110MH2020PTC352733. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Employing 21 professional, Its leadership includes Raj Ranjan Kumar (Director), Kumari Rashmi (Director), Subhangi Kumari (Additional Director). It holds ₹8.80 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No 112 ,Plot No 9, Sector 15,Cbd Belapur,Navi Mumbai, Mumbai, Maharashtra, 400614.
U24110MH2020PTC352733
352733
30 December 2020
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Mediverve Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Ranjan Kumar | Director | 30 Dec 2020 | Current |
| Kumari Rashmi | Director | 30 Dec 2020 | Current |
| Subhangi Kumari | Additional Director | 03 Sep 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediverve Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.53% increase. The company also saw a substantial improvement in profitability, with a 66.06% increase in profit. The company's net worth Soared by an impressive increase of 293.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Mediverve Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹8,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2024 | Others | ₹8.80 M | Open |
Explore comprehensive loan charge details -
Mediverve Laboratories has a workforce of 21 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mediverve Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediverve Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Subhangi Kumari was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2025 & has been associated with this company since 3 months 25 days . was documented.
The activity A charge with Others amounted to Rs. 8.80 M with Charge ID 101035104 was registered on 19 Nov 2024. was completed.
Mediverve Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Mediverve Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Raj Ranjan Kumar was appointed as a Director was appointed as a Director on 30 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Kumari Rashmi was appointed as a Director was appointed as a Director on 30 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
The CIN of Mediverve Laboratories Private Limited is U24110MH2020PTC352733.
Mediverve Laboratories Private Limited is headquartered at Shop No 112 ,Plot No 9, Sector 15,Cbd Belapur,Navi Mumbai, Mumbai, Maharashtra, 400614.
Mediverve Laboratories Private Limited was incorporated on 30 December 2020.
The current directors of Mediverve Laboratories Private Limited are
The primary industry of Mediverve Laboratories Private Limited is Manufacturing.
Mediverve Laboratories Private Limited is unlisted.
The authorized capital of Mediverve Laboratories Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX